BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2816881)

  • 1. Failure of single night-time dose of H2-receptor antagonists in the treatment of duodenal ulcer patients with bulbar stenosis.
    Materia A; Genco A; Silecchia G; Basso N
    Am J Gastroenterol; 1989 Nov; 84(11):1462-3. PubMed ID: 2816881
    [No Abstract]   [Full Text] [Related]  

  • 2. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing.
    Khasawneh SM; Affarah HB
    Am J Gastroenterol; 1992 Sep; 87(9):1180-2. PubMed ID: 1519576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute therapy of duodenal ulcer. Comparison of famotidine and ranitidine in a single evening dose].
    Kimmig JM
    Fortschr Med; 1987 Feb; 105(5):72-6. PubMed ID: 3549493
    [No Abstract]   [Full Text] [Related]  

  • 5. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
    Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
    Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged bedtime treatment with H2-receptor antagonists (ranitidine and famotidine) does not affect blood alcohol levels after ethanol ingestion in male patients with duodenal ulcer.
    Casini A; Pizzigallo AM; Mari F; Bertol E; Surrenti C
    Am J Gastroenterol; 1994 May; 89(5):745-9. PubMed ID: 8172150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Famotidine versus placebo in prevention of the recurrence of duodenal ulcer disease. A multicenter study in Germany, Austria and Italy].
    Baglioni A; Barbara L; Bianchi-Porro G; Blasi A; Canelli B; Cheli R; Dal Monte R; Dammann HG; Francavilla A; Hentschel E
    Z Gastroenterol; 1985 Dec; 23(12):665-9. PubMed ID: 2868581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of the recurrence of duodenal ulcer with famotidine. Report of experiences with long-term therapy in an open clinical study].
    Judmaier G
    Wien Med Wochenschr; 1992; 142(18):406-7. PubMed ID: 1475985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between ranitidine 150 mg b.d. and ranitidine 300 mg nocte in the treatment of duodenal ulcer.
    Arcidiacono R; Benvestito V; Bonomo GM; Bottari M; Buscarini L; Camarri E; Celle G; Coltorti M; Di Matteo S; Dobrilla G
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):381-4. PubMed ID: 3525430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year maintenance treatment with ranitidine: effects on the natural history of duodenal ulcer disease.
    Susi D; Neri M; Ballone E; Mezzetti A; Cuccurullo F
    Am J Gastroenterol; 1994 Jan; 89(1):26-32. PubMed ID: 8273793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of duodenal ulcer with famotidine].
    Schütze K; Hentschel E; Reichel W; Kerstan E
    Wien Med Wochenschr; 1987 Sep; 137(17):409-11. PubMed ID: 2891224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A single evening dose of 300 mg ranitidine in the treatment of acute attacks of gastric and duodenal ulcers. Evaluation of 1,208 patients].
    Bories P; Tournade JM; Alberola B; Pappo M
    Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):227-32. PubMed ID: 3061358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roxatidine in duodenal ulcer.
    Habibullah CM; Habeeb MA; Singh SP
    J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
    Kachintorn U; Chinapak O; Vongphanich V; Kositchaiwat C; Lekhayananda S; Khow-ean U; Suttinont C; Saowaros V; Kludchareon N; Leethochawalit M
    J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Time of famotidine administration and healing of duodenal ulcer: is 18.00 o'clock of importance?].
    Brunner H; Weiss W
    Wien Med Wochenschr; 1992; 142(18):414-7. PubMed ID: 1475987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of famotidine and ranitidine on prostaglandin E2 (PGE2) content of fundic and duodenal mucosa in duodenal ulcer patients.
    Lezoche E; Vagni V; D'Alessandro MD; Mariani P; Carlei F; Lomanto D; Nardovino M; Martelli A; Speranza V
    Drugs Exp Clin Res; 1987; 13(10):655-8. PubMed ID: 2892658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early evening ranitidine administration promotes faster duodenal ulcer healing.
    Merki H; Witzel L; Hüttemann W; Ansari A; Panijel M; Harre K; Heim J; Wolbergs E; Neumann HJ; Röhmel J
    Am J Gastroenterol; 1988 Apr; 83(4):362-4. PubMed ID: 3279756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Famotidine in the short and long-term treatment of duodenal ulcer.
    Zaterka S; de Paula Castro L; Villalobos JJ; Massuda HK; Eisig JN; Dias Avelar C; Coelho LG; Bettarello A
    Acta Gastroenterol Latinoam; 1988; 18(2):115-21. PubMed ID: 3075106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T; Hirata W; Higichi S
    Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of peptic ulcer with ranitidine and cimetidine in a single nocturnal dose].
    Klinger J; Maggiolo P; Arteaga H; Goić A
    Rev Med Chil; 1987 Jul; 115(7):645-7. PubMed ID: 3331025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.